Withdrawal Assessment Tool (WAT-1) for Pediatric Withdrawal

ورودی‌های بالینی بیمار

حداقل ۲۵ — حداکثر ۲۰۰ • واحد: weeks

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
wat 1 score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • None to Mild0–2
  • Mild to Moderate3–8
  • Moderate to Severe9–36
Direct Clinical Answer

The Withdrawal Assessment Tool (WAT-1) for Pediatric Withdrawal calculator is designed for bedside assessing 12 clinical parameters across multiple domains including neurologic irritability, motor symptoms, respiratory distress, and gastrointestinal symptoms to guide withdrawal management in children in clinical practice. The resulting score directly guides clinician.

Clinical Guidelines & Evidence

Validated assessment tool for evaluating opioid and benzodiazepine withdrawal severity in pediatric patients. The WAT-1 systematically assesses 12 clinical parameters across multiple domains including neurologic irritability, motor symptoms, respiratory distress, and gastrointestinal symptoms to guide withdrawal management in children.

Clinical Indication

The Withdrawal Assessment Tool (WAT-1) for Pediatric Withdrawal is indicated for bedside clinical practice to support Validated assessment tool for evaluating opioid and benzodiazepine withdrawal severity in pediatric patients. The WAT-1 systematically assesses 12 clinical parameters across multiple domains including neurologic irritability, motor symptoms, respiratory distress, and gastrointestinal symptoms to guide withdrawal management in children.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.

Limitations & Contraindications

Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients.

Clinical Pearls & Action Plan

Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice.

Formula & Variables:

Sum of scores for 12 withdrawal assessment parameters (0-3 points each): state/sleep-wake cycle + tremor + increased muscle tone + excoriation + myoclonus/seizures + tachypnea + sweating + fever + frequent yawning/sneezing + nasal stuffiness + poor feeding/vomiting. Post-menstrual age affects interpretation thresholds.

Input Parameters

NameTypeRequiredDescription
post_menstrual_age_weeksintegerYesPost-menstrual age in weeks (gestational age + chronological age)(weeks)
state_sleep_wake_cycleintegerYesState/sleep-wake cycle disturbance (0=normal sleep, 1=mild restlessness, 2=moderate agitation, 3=severe sleep disturbance)(points)
tremorintegerYesTremor severity (0=none, 1=mild when stimulated, 2=moderate when awake, 3=severe continuous)(points)
increased_muscle_toneintegerYesIncreased muscle tone/hypertonia (0=normal, 1=mild increase, 2=moderate increase, 3=severe rigidity)(points)
excoriationintegerYesExcoriation marks from scratching (0=none, 1=red marks, 2=scratches without bleeding, 3=bleeding scratches)(points)
myoclonus_seizuresintegerYesMyoclonus/seizure activity (0=none, 1=occasional jerks, 2=frequent jerks, 3=continuous or seizures)(points)
tachypneaintegerYesTachypnea/respiratory distress (0=normal rate, 1=mildly elevated, 2=moderately elevated, 3=severely elevated or distressed)(points)
sweatingintegerYesSweating/diaphoresis (0=none, 1=mild sweating, 2=moderate sweating, 3=profuse sweating)(points)
feverintegerYesFever/hyperthermia (0=<37.2°C, 1=37.2-37.8°C, 2=37.9-38.3°C, 3=>38.3°C)(points)
frequent_yawning_sneezingintegerYesFrequent yawning/sneezing (0=none, 1=occasional, 2=frequent, 3=continuous)(points)
nasal_stuffinessintegerYesNasal stuffiness/rhinorrhea (0=none, 1=mild stuffiness, 2=moderate stuffiness, 3=severe stuffiness)(points)
poor_feeding_vomitingintegerYesPoor feeding/vomiting (0=normal feeding, 1=poor feeding, 2=refusal to feed, 3=vomiting)(points)

Score Interpretation & Guidance

RangeStageDescription
0–2None to MildNo withdrawal or mild withdrawal symptoms
3–8Mild to ModerateMild to moderate withdrawal symptoms
9–36Moderate to SevereModerate to severe withdrawal symptoms

Evidence-Based References (EBM)

  • Franck LS, Harris SK, Soetenga DJ, et al. The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients. Pediatr Crit Care Med. 2008;9(6):573-580. doi: 10.1097/PCC.0b013e31818c8328DOI: 10.1097/PCC.0b013e31818c8328
  • Anand KJ, Willson DF, Berger J, et al. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics. 2010;125(5):e1208-e1225. doi: 10.1542/peds.2009-0489DOI: 10.1542/peds.2009-0489
  • Ista E, van Dijk M, Gamel C, et al. Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. Assessment remains troublesome. Intensive Care Med. 2007;33(8):1396-1406. doi: 10.1007/s00134-007-0696-xDOI: 10.1007/s00134-007-0696-x
  • Best KM, Asaro LA, Franck LS. Patterns of sedation weaning in critically ill children recovering from acute respiratory failure. Pediatr Crit Care Med. 2015;16(3):e43-e49. doi: 10.1097/PCC.0000000000000324DOI: 10.1097/PCC.0000000000000324

Related calculators